Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension

NCT02322450 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: QGC001
DRUG: Placebo

Sponsor

Quantum Genomics SA